Blue Horseshoe Stocks- AEZS Recap & More

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

bluehorseshoestocks Newsletter

———————————————————— ** ———————————————————— ———————————————————— AEterna Zentaris, Inc. AEZS We called AEZS in yesterday morning`s newsletter ( as a potential bottom play to kick off the week, and our timing really couldn`t have been much better. After opening at .55, it would run to as much as .65; a solid intraday increase totaling 18% Any time we can make a quick profit off of a stock coming off of its all-time lows we consider it a big success, and will continue to monitor this stock for further opportunities it may present with any continuing rebound action.

The turnaround came in conjunction with a PR notice that AEterna had signed a license and technology transfer agreement pertaining to the company`s “doxorubicin” anti-cancer compound with Sinopharm A-Think Pharmaceuticals, a division of China`s largest pharmaceutical company. >> Read PR ( ———————————————————— Energy XXI (EXXI) – Bottom Watch Speaking of stocks trading at landmark low points, as an apparent result of the continued slide in oil prices in addition to a recent financial update that was poorly-received, EXXI has come down to find new 52-week lows.

We`re going to put this stock on bottom-watch, while noting that further losses for crude could actually cause it to continue pushing its lower boundary. That certainly seems to be the opinion of some analysts, but as ever, where others see lost ground, we see opportunity on the horizon.

Either way it shakes out, we could see a substantial recovery of the EXXI chart once oil prices begin to rebound, so we`ll tag it for our ongoing watchlist and monitor the situation moving forward.

———————————————————— ============================================================

** follow on Twitter ( | ** friend on Facebook (#) | ** forward to a friend ( Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. ** Our disclaimer ( is to be read and fully agreed to before using our site, or joining our email list. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions, however any that may occur will be corrected as needed. BHS and its affiliates are not registered or licensed investment advisers, nor broker dealers. BHS cautions that the investments in companies profiled are commonly considered to be extremely high risk and use of any information provided is at the investor`s sole risk.

Copyright © 2014, All rights reserved.


** EquityFeed ( CLICK TO SIGN UP TODAY! **

This entry was posted in Stock Newsletters and tagged , . Bookmark the permalink.

Comments are closed.